Blog Blog Subscription Email* Untitled Blog Subscription Clinical Health Plans Health Systems Life Sciences Our Take Kay LeChien, M.S., CGC, Genetic Analyst; Tricia Page, M.S., CGC, Genetic Analyst|February 23, 2021February 22, 2021ClinicalHealth PlansHealth Systems Whole Exome Sequencing: How is it being used? David Nixon, CEO, and Rebecca Sutphen, Co-founder and Chief Medical Officer|January 29, 2021January 28, 2021Health PlansHealth SystemsLife SciencesOur Take Three Genetic Discovery Trends for 2021 David Nixon, CEO, and Rebecca Sutphen, Co-founder and Chief Medical Officer|January 25, 2021January 28, 2021Health PlansHealth SystemsLife SciencesOur Take “That’s a wrap!” Our 2020 in Review Heather Dorsey, Evidence Review Manager, M.S., CGC|January 11, 2021January 11, 2021Health Plans FDA: Drugs, Devices, and Genetics Virginia Anne Adams M.S., CGC; Marie Scheutzle M.S., CGC; Tricia Page M.S., CGC; Alisha Wilkens M.S., CGC|December 16, 2020December 18, 2020ClinicalHealth Systems Considerations for Expanded Carrier Screening Whitney Ducaine, M.G.C., CGC, CN-BM, Director, Cancer Genetics Services|November 30, 2020January 15, 2021ClinicalHealth Systems Patient-Centered Cancer Care: Somatic vs. Germline Testing and the Role of Genetic Counselors Marie Scheutzle, M.S., CGC; Rachel Utesch, RN CN-BN|November 12, 2020November 16, 2020ClinicalHealth Systems Reproductive Genetics and Telegenetic Counseling: How It Works InformedDNA|October 28, 2020January 14, 2021Life Sciences Solving Patient Identification and Recruitment Challenges With Clinical Genetics Expertise InformedDNA|October 15, 2020November 25, 2020Health Plans The In’s and Out’s of Genetic Testing Payment Integrity InformedDNA|September 28, 2020November 25, 2020Life Sciences Rare Disease Clinical Trials During COVID-19: 4 Lessons Learned 1 2 3 … 6 Next Let's talk about your genetic services needs. First Name*Last Name*TitleCompany*Business Email Address* PhoneMessage Opt-in for email list? CAPTCHA
Kay LeChien, M.S., CGC, Genetic Analyst; Tricia Page, M.S., CGC, Genetic Analyst|February 23, 2021February 22, 2021ClinicalHealth PlansHealth Systems Whole Exome Sequencing: How is it being used?
David Nixon, CEO, and Rebecca Sutphen, Co-founder and Chief Medical Officer|January 29, 2021January 28, 2021Health PlansHealth SystemsLife SciencesOur Take Three Genetic Discovery Trends for 2021
David Nixon, CEO, and Rebecca Sutphen, Co-founder and Chief Medical Officer|January 25, 2021January 28, 2021Health PlansHealth SystemsLife SciencesOur Take “That’s a wrap!” Our 2020 in Review
Heather Dorsey, Evidence Review Manager, M.S., CGC|January 11, 2021January 11, 2021Health Plans FDA: Drugs, Devices, and Genetics
Virginia Anne Adams M.S., CGC; Marie Scheutzle M.S., CGC; Tricia Page M.S., CGC; Alisha Wilkens M.S., CGC|December 16, 2020December 18, 2020ClinicalHealth Systems Considerations for Expanded Carrier Screening
Whitney Ducaine, M.G.C., CGC, CN-BM, Director, Cancer Genetics Services|November 30, 2020January 15, 2021ClinicalHealth Systems Patient-Centered Cancer Care: Somatic vs. Germline Testing and the Role of Genetic Counselors
Marie Scheutzle, M.S., CGC; Rachel Utesch, RN CN-BN|November 12, 2020November 16, 2020ClinicalHealth Systems Reproductive Genetics and Telegenetic Counseling: How It Works
InformedDNA|October 28, 2020January 14, 2021Life Sciences Solving Patient Identification and Recruitment Challenges With Clinical Genetics Expertise
InformedDNA|October 15, 2020November 25, 2020Health Plans The In’s and Out’s of Genetic Testing Payment Integrity
InformedDNA|September 28, 2020November 25, 2020Life Sciences Rare Disease Clinical Trials During COVID-19: 4 Lessons Learned